Corrigendum to “Metformin-mediated protection against doxorubicin-induced cardiotoxicity” [Biomed. Pharmacother., 180, (2024), 117535] - 21/05/26
Doi : 10.1016/j.biopha.2026.119452
Ming-Li Sun a, ⁎ 
, Jun-Min Dong a, Chen Liu a, Pu Li a, Chao Zhang b, Jie Zhen c, Wei Chen c, ⁎
, Jun-Min Dong a, Chen Liu a, Pu Li a, Chao Zhang b, Jie Zhen c, Wei Chen c, ⁎ a Phase I Clinical Trial Research Center, Beijing Shijitan Hospital Affiliated to Capital Medical University, Beijing 100038, China
b Department of Ultrasonography, Beijing Chaoyang Hospital affiliated to Capital Medical University, Beijing 100020, China
c Department of Intensive Care Unit, Beijing Shijitan Hospital Affiliated to Capital Medical University, Beijing 100038, China
⁎ Corresponding authors.
Le texte complet de cet article est disponible en PDF.
© 2026
The Authors. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 199
Article 119452- juin 2026 Retour au numéro
Article précédent
- Corrigendum to “Inhibition of the mitochondrial permeability transition pore as a promising target for protecting auditory function in cisplatin-induced hearing loss” [Biomed. Pharmacother. 182 (2025) 117767]
- Ye-Ri Kim, Sujin Jun, Sunhwa Jung, Byeonghyeon Lee, Sang-Hee Lee, Jaehyuk Lee, Jong-Su Hwang, Themis Thoudam, Hoyul Lee, Ibotombi Singh Sinam, Jae-Han Jeon, Kyu-Yup Lee, Sun-Joon Min, Un-Kyung Kim
- Corrigendum to “Dioscin alleviates Alzheimer's disease through regulating RAGE/NOX4 mediated oxidative stress and inflammation” [Biomed. Pharmacother. 152 (2022) 113248]
- Linshu Guan, Zhang Mao, Sen Yang, Guanlin Wu, Yurong Chen, Lianhong Yin, Yan Qi, Lan Han, Lina Xu
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?